Long-term outcomes of low-dose dasatinib in older patients with chronic myeloid leukemia in chronic phase: an extended follow-up of the DAVLEC phase 2 trial.
Saved in:
| Title: | Long-term outcomes of low-dose dasatinib in older patients with chronic myeloid leukemia in chronic phase: an extended follow-up of the DAVLEC phase 2 trial. |
|---|---|
| Authors: | Ureshino H; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan. sr0795@cc.saga-u.ac.jp., Murai K; Department of Hematology, Iwate Prefectural Central Hospital, Morioka, Japan., Kumagai T; Department of Hematology, Ome Medical Center, Ome, Japan., Mino T; Department of Hematology, Hiroshima City Asa Hospital, Hiroshima, Japan., Nishiwaki K; Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University Kashiwa Hospital, Kashiwa, Japan., Wakita S; Department of Hematology, Nippon Medical School, Tokyo, Japan., Takeoka T; Division of Hematology and Immunology, Japanese Red Cross Otsu Hospital, Otsu, Japan., Mita M; Department of Hematology, Shirakawa Kosei General Hospital, Shirakawa, Japan., Yoshida C; Department of Hematology, National Hospital Organization Mito Medical Center, Ibaraki, Japan., Uoshima N; Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan., Fukushima T; Department of Hematology and Immunology, Kanazawa Medical University, Kanazawa, Japan., Kuroda J; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan., Kondo T; Blood Disorders Center, Aiiku Hospital, Sapporo, Japan., Chiba M; Department of Hematology, Asahikawa City Hospital, Asahikawa, Japan., Miyazaki T; Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan., Io K; Department of Hematology, Kansai Electric Power Hospital, Osaka, Japan., Ueda T; Department of Hematology and Oncology, The University of Osaka, Suita, Japan., Ono T; Divison of Hematology, Hamamatsu University School of Medicine, Hamamatsu, Japan., Usuki K; Forth Department of Internal Medicine, Mizonokuchi Hospital, Teikyo University School of Medicine, Itabashi City, Japan., Yamauchi T; Department of Hematology and Oncology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan., Fujimaki K; Department of Hematology, Fujisawa City Hospital, Fujisawa, Japan., Ikezoe T; Department of Hematology, Fukushima Medical University, Fukushima, Japan., Kawaguchi A; Education and Research Center for Community Medicine, Faculty of Medicine, Saga University, Saga, Japan., Kimura S; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan. |
| Source: | Blood cancer journal [Blood Cancer J] 2026 May 28; Vol. 16 (1). Date of Electronic Publication: 2026 May 28. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
